Clinical trial
Comparison of Thrombectomy and Standard Care for Ischemic Stroke in Patients Ineligibility for Tissue Plasminogen Activator Treatment
NCT02135926 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Thrombectomy and Standard Care for Ischemic Stroke in Patients Ineligibility for Tissue Plasminogen Activator Treatment
- Lead sponsor
- University Hospital Heidelberg
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 31, 2014
- Completion date
- February 1, 2017
- Enrollment
- 4 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.